-
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
(PA-20-242)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 Clinical Trial Not Allowed)
(PAR-20-239)
National Institute of General Medical Sciences
Application Receipt Date(s): September 4, 2020; September 3, 2021; September 2, 2022
-
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
(PAR-20-240)
National Institute of Neurological Disorders and Stroke
National Institute of Mental Health
Application Receipt Date(s): January 25, 2021, September 27, 2021, and September 26, 2022
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)
(PAR-20-241)
National Institute on Drug Abuse
Application Receipt Date(s): October 30, 2020
-
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)
(PAR-20-243)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): August 20, 2020, December 2 , 2020, March 2, 2021
-
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 Clinical Trial Not Allowed)
(PAR-20-244)
National Institute of General Medical Sciences
Application Receipt Date(s): September 4, 2020; September 3, 2021; September 2 , 2022
-
Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
(RFA-AA-20-010)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): October 7, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Funding Opportunity Announcement..
-
Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44 Clinical Trial Not Allowed)
(RFA-AG-21-026)
National Institute on Aging
Application Receipt Date(s): November 10, 2020
-
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
(RFA-CA-20-042)
National Cancer Institute
Application Receipt Date(s): November 9, 2020
-
Characterizing causal mechanisms to prevent dental fear and anxiety (R01 Basic Experimental Studies with Humans Required)
(RFA-DE-21-001)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): November 10, 2020
-
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project (U24 Clinical Trial Not Allowed)
(RFA-HD-21-008)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Application Receipt Date(s): December 3, 2020